The study of Chen et al. additionally showed that the LIN28/let-7 pathway was involved in the immune evasion of breast cancer cells amongst others, which lead to therapy resistance to programmed death receptor-1 (PD-1)/programmed death-receptor-ligand-1 (PD-L1) immune checkpoint therapeutics. The gene discussed is CD274; the disease is breast cancer.